The Development of Malignant Tumours of Mouse Skin After 'Initiating' and 'Promoting' Stimuli
1956

Effects of Dividing Carcinogen Doses on Tumor Development in Mice

Sample size: 120 publication Evidence: moderate

Author Information

Author(s): M. H. Salaman, F. J. C. Roe

Primary Institution: London Hospital Medical College

Hypothesis

Does splitting the dose of DMBA into two halves increase the incidence of malignant tumors in mice?

Conclusion

Splitting the initiating dose of DMBA into two halves appears to favor the induction of malignant tumors, especially with longer intervals between doses.

Supporting Evidence

  • 43 out of 106 surviving mice developed malignant tumors after treatment.
  • Groups receiving two half-doses had a higher incidence of tumors than those receiving a single dose.
  • Statistical analysis was complicated due to the nature of the data collected.

Takeaway

When scientists gave mice a cancer-causing chemical in two smaller doses instead of one big dose, they found more tumors, especially if they waited a few weeks between doses.

Methodology

Mice were divided into groups and treated with DMBA and croton oil, with varying intervals between doses to observe tumor development.

Limitations

The statistical significance of the results could not be adequately tested.

Participant Demographics

60 male and 60 female mice were used in the study.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication